| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| iSpecimen Inc. | Director | Option | 168 | $860 | $5.12 | 25 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENTO | Entero Therapeutics, Inc. | 03 Feb 2025 | 0 | $0 | 3 | Interim CEO, Director | 13 Feb 2025, 16:59 |
| ISPC | iSpecimen Inc. | 25 Sep 2024 | 1 | $860 | 4 | Director | 27 Sep 2024, 19:20 |
| ISPC | iSpecimen Inc. | 25 Sep 2024 | 0 | $0 | 3 | Director | 27 Sep 2024, 19:17 |